v3.26.1
Condensed Consolidated Interim Statements of Changes In Equity - USD ($)
$ in Thousands
Share capital
Additional paid in capital
Capital reserve due to translation to presentation currency
Capital reserve from hedges
Capital reserve from share based payments
Capital reserve from employee benefits
Accumulated deficit
Total
Balance at Dec. 31, 2024 $ 15,028 $ 266,933 $ (3,490) $ 51 $ 6,316 $ 364 $ (25,738) $ 259,464
Net income 3,964 3,964
Other comprehensive income (loss), net of tax (168) 8 (160)
Total comprehensive income (loss) (168) 8 3,964 3,804
Exercise and forfeiture of share-based payment into shares 46 1,227 (1,227) 46
Cost of share-based payment 177 177
Dividend declared (11,534) (11,534)
Balance at Mar. 31, 2025 15,074 268,160 (3,490) (117) 5,266 372 (33,308) 251,957
Balance at Dec. 31, 2024 15,028 266,933 (3,490) 51 6,316 364 (25,738) 259,464
Net income 20,198 20,198
Other comprehensive income (loss), net of tax 126 21 147
Total comprehensive income (loss) 126 21 20,198 20,345
Exercise and forfeiture of share-based payment into shares 50 1,450 (1,450) 50
Cost of share-based payment 845 845
Dividend declared (11,534) (11,534)
Income tax impact associated with issuance of shares (100) (100)
Balance at Dec. 31, 2025 15,078 268,283 (3,490) 177 5,711 385 (17,074) 269,070
Net income 4,132 4,132
Other comprehensive income (loss), net of tax (183) (11) (194)
Total comprehensive income (loss) (183) (11) 4,132 3,938
Exercise and forfeiture of share-based payment into shares 77 (77)
Cost of share-based payment 800 800
Dividend declared (14,421) (14,421)
Balance at Mar. 31, 2026 $ 15,078 $ 268,360 $ (3,490) $ (6) $ 6,434 $ 374 $ (27,363) $ 259,387